NCT00141544

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Solvay Pharmaceuticals · Industry
• Sex: Female
• Age: 35 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To determine whether treatment with ESTRATEST® Tablets is superior to treatment with esterified estrogens tablets

Conditions

• Menopause

Interventions

Type	Name	Description
DRUG	esterified estrogens 1.25 mg and methyltestosterone 2.5 mg	ESTRATEST® administered orally QD
DRUG	Esterified estrogens 1.25 mg	Esterified estrogens 1.25 mg administered orally QD

Timeline

• Start date: 2004-07-01
• Primary completion: 2007-04-01
• Completion: 2008-03-01
• First posted: 2005-09-01
• Last updated: 2008-04-11

Locations

78 sites across 1 country: United States